CN Patent

CN102488652B — 含有药物-离子交换树脂复合物的经修饰释放的制剂

Assigned to Tris Pharma Inc · Expires 2014-06-18 · 12y expired

What this patent protects

本发明提供一种经涂覆的药物-离子交换树脂复合物，其包含由药物与药学上可接受的离子-交换树脂复合所组成的核心。药物-离子交换树脂复合物与释放延缓剂混合。涂料包含聚乙酸乙烯酯聚合物和增塑剂。描述了制造方法及包含这种经涂覆的复合物的产品。

USPTO Abstract

本发明提供一种经涂覆的药物-离子交换树脂复合物，其包含由药物与药学上可接受的离子-交换树脂复合所组成的核心。药物-离子交换树脂复合物与释放延缓剂混合。涂料包含聚乙酸乙烯酯聚合物和增塑剂。描述了制造方法及包含这种经涂覆的复合物的产品。

Drugs covered by this patent

Patent Metadata

Patent number: CN102488652B
Jurisdiction: CN
Classification: —
Expires: 2014-06-18
Drug substance claim: No
Drug product claim: No
Assignee: Tris Pharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.